vs
Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and TRANSACT TECHNOLOGIES INC (TACT). Click either name above to swap in a different company.
TRANSACT TECHNOLOGIES INC is the larger business by last-quarter revenue ($11.5M vs $7.8M, roughly 1.5× CRYO CELL INTERNATIONAL INC). On growth, TRANSACT TECHNOLOGIES INC posted the faster year-over-year revenue change (11.9% vs -2.3%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $589.0K). Over the past eight quarters, TRANSACT TECHNOLOGIES INC's revenue compounded faster (3.5% CAGR vs -0.1%).
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
Roper Technologies, Inc. is a holding company that owns companies in the technology sector.
CCEL vs TACT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.8M | $11.5M |
| Net Profit | $-3.8M | — |
| Gross Margin | 77.9% | 47.6% |
| Operating Margin | -50.6% | -10.1% |
| Net Margin | -48.7% | — |
| Revenue YoY | -2.3% | 11.9% |
| Net Profit YoY | -105.1% | — |
| EPS (diluted) | $-0.46 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.8M | $11.5M | ||
| Q3 25 | $7.8M | $13.2M | ||
| Q2 25 | $7.9M | $13.8M | ||
| Q1 25 | $8.0M | $13.1M | ||
| Q4 24 | $8.0M | $10.2M | ||
| Q3 24 | $8.1M | $10.9M | ||
| Q2 24 | $8.0M | $11.6M | ||
| Q1 24 | $7.9M | $10.7M |
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $749.4K | $15.0K | ||
| Q2 25 | $355.8K | $-143.0K | ||
| Q1 25 | $282.9K | $19.0K | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $1.1M | $-551.0K | ||
| Q2 24 | $655.8K | $-319.0K | ||
| Q1 24 | $556.2K | $-1.0M |
| Q4 25 | 77.9% | 47.6% | ||
| Q3 25 | 77.0% | 49.8% | ||
| Q2 25 | 76.6% | 48.2% | ||
| Q1 25 | 75.1% | 48.7% | ||
| Q4 24 | 78.4% | 44.2% | ||
| Q3 24 | 73.6% | 48.1% | ||
| Q2 24 | 74.8% | 52.7% | ||
| Q1 24 | 73.7% | 52.6% |
| Q4 25 | -50.6% | -10.1% | ||
| Q3 25 | 24.3% | 0.1% | ||
| Q2 25 | 18.8% | -1.9% | ||
| Q1 25 | 13.3% | -0.1% | ||
| Q4 24 | -1.5% | -10.3% | ||
| Q3 24 | 17.2% | -7.7% | ||
| Q2 24 | 17.3% | -3.8% | ||
| Q1 24 | 10.5% | -12.2% |
| Q4 25 | -48.7% | — | ||
| Q3 25 | 9.6% | 0.1% | ||
| Q2 25 | 4.5% | -1.0% | ||
| Q1 25 | 3.5% | 0.1% | ||
| Q4 24 | -23.2% | — | ||
| Q3 24 | 13.0% | -5.1% | ||
| Q2 24 | 8.2% | -2.8% | ||
| Q1 24 | 7.1% | -9.7% |
| Q4 25 | $-0.46 | $-0.11 | ||
| Q3 25 | $0.09 | $0.00 | ||
| Q2 25 | $0.04 | $-0.01 | ||
| Q1 25 | $0.03 | $0.00 | ||
| Q4 24 | $-0.23 | $-0.80 | ||
| Q3 24 | $0.13 | $-0.06 | ||
| Q2 24 | $0.08 | $-0.03 | ||
| Q1 24 | $0.07 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3M | $20.4M |
| Total DebtLower is stronger | $8.4M | — |
| Stockholders' EquityBook value | $-18.6M | $31.1M |
| Total Assets | $61.7M | $44.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.3M | $20.4M | ||
| Q3 25 | $3.2M | $20.0M | ||
| Q2 25 | $4.4M | $17.7M | ||
| Q1 25 | $3.5M | $14.2M | ||
| Q4 24 | $3.5M | $14.4M | ||
| Q3 24 | $2.1M | $11.3M | ||
| Q2 24 | $1.5M | $11.1M | ||
| Q1 24 | $979.6K | $10.6M |
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
| Q4 25 | $-18.6M | $31.1M | ||
| Q3 25 | $-14.8M | $31.8M | ||
| Q2 25 | $-15.6M | $31.3M | ||
| Q1 25 | $-14.7M | $30.9M | ||
| Q4 24 | $-13.2M | $30.6M | ||
| Q3 24 | $-9.6M | $38.4M | ||
| Q2 24 | $-10.7M | $38.5M | ||
| Q1 24 | $-10.3M | $38.6M |
| Q4 25 | $61.7M | $44.8M | ||
| Q3 25 | $63.2M | $45.0M | ||
| Q2 25 | $64.4M | $44.5M | ||
| Q1 25 | $64.4M | $44.2M | ||
| Q4 24 | $64.7M | $44.0M | ||
| Q3 24 | $62.9M | $50.5M | ||
| Q2 24 | $62.6M | $50.4M | ||
| Q1 24 | $61.7M | $51.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $609.0K |
| Free Cash FlowOCF − Capex | $1.2M | $589.0K |
| FCF MarginFCF / Revenue | 15.5% | 5.1% |
| Capex IntensityCapex / Revenue | 0.9% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.2M | $7.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3M | $609.0K | ||
| Q3 25 | $2.5M | $3.6M | ||
| Q2 25 | $707.0K | $3.6M | ||
| Q1 25 | $954.1K | $-161.0K | ||
| Q4 24 | $2.2M | $2.4M | ||
| Q3 24 | $2.4M | $327.0K | ||
| Q2 24 | $1.8M | $636.0K | ||
| Q1 24 | $-356.9K | $-1.5M |
| Q4 25 | $1.2M | $589.0K | ||
| Q3 25 | $2.5M | $3.6M | ||
| Q2 25 | $644.6K | $3.6M | ||
| Q1 25 | $892.0K | $-171.0K | ||
| Q4 24 | $2.1M | $2.4M | ||
| Q3 24 | $2.3M | $259.0K | ||
| Q2 24 | $21.5K | $499.0K | ||
| Q1 24 | $-814.6K | $-1.6M |
| Q4 25 | 15.5% | 5.1% | ||
| Q3 25 | 31.9% | 27.1% | ||
| Q2 25 | 8.1% | 25.9% | ||
| Q1 25 | 11.2% | -1.3% | ||
| Q4 24 | 26.8% | 23.2% | ||
| Q3 24 | 27.9% | 2.4% | ||
| Q2 24 | 0.3% | 4.3% | ||
| Q1 24 | -10.4% | -14.9% |
| Q4 25 | 0.9% | 0.2% | ||
| Q3 25 | 0.5% | 0.5% | ||
| Q2 25 | 0.8% | 0.1% | ||
| Q1 25 | 0.8% | 0.1% | ||
| Q4 24 | 0.1% | 0.1% | ||
| Q3 24 | 2.3% | 0.6% | ||
| Q2 24 | 21.8% | 1.2% | ||
| Q1 24 | 5.8% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | 3.38× | 242.00× | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 3.37× | -8.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.70× | — | ||
| Q1 24 | -0.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
